Hikal - for me a high conviction bet now as buying volumes are high and stock is retesting the support. SL 495. Buy zone 525-535
More from Steve Nison
Laurus Labs - Double top buy will be activated above closing of 690. Target still active: 895 (1%*3 box size and reversal)
✅✅ https://t.co/MtJOLfpzYj
✅✅ https://t.co/MtJOLfpzYj
Laurus Labs - I am waiting till 3:15 PM to get confirmation of closing above 700 to add more of it in my portfolio. \u2705\u2705 pic.twitter.com/UxZCuxhuIX
— Steve Nison (@nison_steve) August 9, 2021
More from Hikal
Key insights from Hikal
🧪 Lowered interest rates
🧪 Pharma: Growth in generics as well as CDMO
🧪 Crop Protection: Scaleup of a fungicide for a Japanese CDMO client
🧪 Healthy pipeline of new products: Supported by new capacities; Investing in Animal Health & Biocides verticals https://t.co/D70j9oriCa
🧪 Lowered interest rates
🧪 Pharma: Growth in generics as well as CDMO
🧪 Crop Protection: Scaleup of a fungicide for a Japanese CDMO client
🧪 Healthy pipeline of new products: Supported by new capacities; Investing in Animal Health & Biocides verticals https://t.co/D70j9oriCa
Hikal: Strong
— JST Investments (@JstInvestments) August 5, 2021
\U0001f9ea Rev up 27% YoY
\U0001f9ea 22% EBITDA margin
\U0001f9ea Pat of 50crs
\U0001f9ea Growth across both pharmaceuticals & crop protection.#Q1withJST #Pharma pic.twitter.com/8lFo68KzPe